Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.49 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3861084 | 1.00 | APP (0.53) | APPALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL2229143 | 1.00 | APP (0.53) | APPALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL8371513 | 0.91 | ALDH1A1 (0.59) | APPALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL19389642 | 0.90 | ALDH1A1 (0.53) | APPALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL145373 | 0.89 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2LMNAMAPTHPGD | |
| SCHEMBL22190238 | 0.88 | APP (0.68) | APPALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL11685734 | 0.86 | ALDH1A1 (0.50) | APPALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL22190246 | 0.86 | APP (0.59) | APPALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL22190239 | 0.86 | APP (0.59) | APPALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL21959668 | 0.85 | APP (0.58) | APPALDH1A1SMN1; SMN2LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112500325-A | Alpha, omega-type chain transfer agent for reversible addition-fragmentation chain transfer RAFT polymerization, and preparation method and application thereof | 北京吉乃尔科技有限公司 | 2021-03-16 | — | — | CN | claimed |
| US-11814402-B2 | Binuclear palladacycles and their use in the treatment of cancer | STELLENBOSCH UNIVERSITY (ZA) | 2023-11-14 | — | — | US | disclosed |
| US-11814402-B2 | Binuclear palladacycles and their use in the treatment of cancer | STELLENBOSCH UNIVERSITY (ZA) | 2023-11-14 | — | — | US | disclosed |
| US-11814402-B2 | Binuclear palladacycles and their use in the treatment of cancer | STELLENBOSCH UNIVERSITY (ZA) | 2023-11-14 | — | — | US | disclosed |
| CN-116947641-A | Polymerizable photoinitiator containing diphenyl ketone structure and preparation method thereof | 宁波力合博汇光敏材料有限公司 | 2023-10-27 | — | — | CN | disclosed |
| EP-3752513-B1 | BINUCLEAR PALLADACYCLES AND THEIR USE IN THE TREATMENT OF CANCER | UNIV STELLENBOSCH (ZA) | 2021-10-20 | — | — | EP | disclosed |
| CN-112500325-A | Alpha, omega-type chain transfer agent for reversible addition-fragmentation chain transfer RAFT polymerization, and preparation method and application thereof | 北京吉乃尔科技有限公司 | 2021-03-16 | — | — | CN | disclosed |
| CN-112500325-A | Alpha, omega-type chain transfer agent for reversible addition-fragmentation chain transfer RAFT polymerization, and preparation method and application thereof | 北京吉乃尔科技有限公司 | 2021-03-16 | — | — | CN | disclosed |
| CN-108440251-B | Method for photo/nickel concerted catalysis of monoarylation diol | 陕西师范大学 | 2021-01-01 | — | — | CN | disclosed |
| EP-3752513-A1 | BINUCLEAR PALLADACYCLES AND THEIR USE IN THE TREATMENT OF CANCER | Stellenbosch University (ZA) | 2020-12-23 | — | — | EP | disclosed |
| US-20040204510-A1 | High internal phase emulsion foams containing polyelectrolytes | 3M INNOVATIVE PROPERTIES COMPANY | 2004-10-14 | — | — | US | disclosed |
| US-6750261-B1 | High internal phase emulsion foams containing polyelectrolytes | 3M INNOVATIVE PROPERTIES COMPANY | 2004-06-15 | — | — | US | disclosed |
| EP-0885408-B1 | A SCREEN PRINTING STENCIL | SERICOL LTD (GB) | 2001-10-17 | — | — | EP | disclosed |
| US-5994033-A | GRAFT POLYMER | SERICOL LIMITED (GB) | 1999-11-30 | — | — | US | disclosed |
| EP-0885408-A1 | A SCREEN PRINTING STENCIL | SERICOL LIMITED (GB) | 1998-12-23 | — | — | EP | disclosed |
| US-5674561-A | APPLYING TO BACKING A POLYMER BLEND HAVING COEXISTING CONTINUOUS HYDROPHILIC AND HYDROPHOBIC SOLID PHASES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-10-07 | — | — | US | disclosed |
| WO-1997033202-A1 | A SCREEN PRINTING STENCIL | SERICOL LIMITED (GB) | 1997-09-12 | — | — | WO | disclosed |
| EP-0594702-A1 | SUBSTITUTED INDOLES AS ANTI-AIDS PHARMACEUTICALS. | UPJOHN CO (US) | 1994-05-04 | — | — | EP | disclosed |
| US-5091274-A | Modified polysiloxanes | NATIONAL SCIENCE COUNCIL (TW) | 1992-02-25 | — | — | US | disclosed |
| US-4053415-A | UNSATURATED POLYESTER ETHER HAVING A PHOTOCROSSLINKABLE MOIETY | FUJI PHOTO FILM CO., LTD. (JA) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814402-B2 | Binuclear palladacycles and their use in the treatment of cancer | BCL3, CCNO, CCNE2 | APP 4861/4885ALDH1A1 985/4885SMN1; SMN2 2338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.